Rare lephants
Screener

Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jan 6, 2021 FORM 4 SUBMISSION
4 Jan 5, 2021 FORM 4 SUBMISSION
3 Jan 5, 2021 FORM 3 SUBMISSION
4 Dec 18, 2020 PRIMARY DOCUMENT
4 Dec 18, 2020 FORM 4 SUBMISSION
8-K Dec 17, 2020 8-K
SC 13D/A Dec 7, 2020 AMENDMENT NO. 5 TO SC 13D
8-K Dec 3, 2020 8-K
4 Dec 2, 2020 FORM 4 SUBMISSION
3 Dec 2, 2020 FORM 3 SUBMISSION
424B5 Nov 13, 2020 424B5
4 Nov 10, 2020 PRIMARY DOCUMENT
4 Nov 6, 2020 PRIMARY DOCUMENT
4 Nov 5, 2020 FORM 4 SUBMISSION
8-K Nov 5, 2020 8-K
10-Q Nov 5, 2020 10-Q
8-K Oct 28, 2020 8-K
4 Oct 27, 2020 FORM 4 SUBMISSION
4 Oct 27, 2020 FORM 4 SUBMISSION
4 Oct 27, 2020 FORM 4 SUBMISSION
4 Oct 27, 2020 FORM 4 SUBMISSION
4 Oct 27, 2020 FORM 4 SUBMISSION
4 Oct 27, 2020 FORM 4 SUBMISSION
4 Oct 27, 2020 FORM 4 SUBMISSION
4 Oct 27, 2020 FORM 4 SUBMISSION
← Newer Page 13 of 21 · 513 filings Older →